tlag‽ [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2017-12-21 16:41 (2684 d 16:55 ago) – Posting: # 18077
Views: 8,376

Hi nobody,

❝ ...somebody had a look at the ADRs (mostly upper GI-tract-related, therefore the gastroresistant formulation) and said, hey, we have to "quantitate" the quality of the gastroresistant part of the formulations. Let's do tlag!


Splendid idea! Why not an early partial AUC?

❝ afaik the SmPC recommends application in fed state, due to better tolerability.


Yep.

❝ The EMA guideline gives no recommendation re. fasted/fed?!


Strange. The MR-GL suggests for delayed release multiple unit formulations (if SmPC recommends intake under fed conditions): SD fasting and fed.

❝ On the other hand: Modified release with one single-dose study only?


Do you mean why no MD study? That’s consistent with the MR-GL.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
99 visitors (0 registered, 99 guests [including 11 identified bots]).
Forum time: 10:37 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5